Cell permeable vanX inhibitors as vancomycin re-sensitizing agents

Ramaiah Muthyala, Namrata Rastogi, Woo Shik Shin, Marnie L. Peterson, Yuk Yin Sham

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


VanX is an induced zinc metallo d-Ala-d-Ala dipeptidase involved in the viable remodeling of bacterial cell wall that is essential for the development of VREF. Here we report two cyclic thiohydroxamic acid-based peptide analogs that were designed, synthesized and investigated as vancomycin re-sensitizing agents. These compounds exhibit low micromolar inhibitory activity against vanX, with low cytotoxicity and were shown to increase vancomycin sensitivity against VREF. The improved pharmacological properties of these novel inhibitors over previous transition state mimics should provide an enhanced platform for designing potent vanX inhibitors for overcoming vancomycin resistance.

Original languageEnglish (US)
Pages (from-to)2535-2538
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Issue number11
StatePublished - Jun 1 2014

Bibliographical note

Funding Information:
We thank Prof. Christopher Walsh for providing the plasmid used in the expression of vanX. This research was supported by the faculty development grant from the University of Minnesota Academic Health Center . We thank the University of Minnesota Supercomputing Institute and the Center for Drug Design for providing the necessary computational and instrumentation resources. We thank Dr. Fred Schendel, Biotechnology Institute, University of Minnesota for vanX protein preparation. We also thank Jesse Meyer for performing the biochemical assays.


  • Antibiotics
  • Drug resistance
  • Pyrithione
  • Thiohydroxamic acid
  • VanX
  • Vancomycin


Dive into the research topics of 'Cell permeable vanX inhibitors as vancomycin re-sensitizing agents'. Together they form a unique fingerprint.

Cite this